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Summary 
The switch from short- to long-term facilitation in- 
duced by behavioral sensitization in Aplysia involves 
CREB-like proteins, as well as the immediate-early 
gene ApCIEBP. Using the bZlP domain of ApC/EBP 
in a two-hybrid system, we have cloned ApCREB2, a 
transcription factor constitutively expressed in sen- 
sory neurons that resembles human CREBS and 
mouse ATF4. ApCREBP represses ApCREBl -me- 
diated transcription in F9 cells. Injection of anti- 
ApCREB2 antibodies into Aplysia sensory neurons 
causes a single pulse of serotonin (5HT), which in- 
duces only short-term facilitation lasting minutes, to 
evoke facilitation lasting more than 1 day. This facilita- 
tion has the properties of long-term facilitation: it re- 
quires transcription and translation, induces the 
growth of new synapticconnections, and occludesfur- 
ther facilitation by five pulses of 5HT. 
Introduction 
Memory acquisition has at least two components: a tran- 
sient short-term memory lasting minutes to hours can be 
followed by a more persistent and self-maintained long- 
term memory lasting days to years. Whereas short-term 
memory requires only covalent modifications of preex- 
isting proteins, long-term memory requires the synthesis 
of new mRNA and proteins (Flexner et al., 1963; Davis 
and Squire, 1984; Montarolo et al., 1986) and is accompa- 
nied by the growth of new synaptic connections (Bailey 
and Kandel, 1993). 
The switch from short- to long-term memory can be stud- 
ied on the molecular level in the gill-withdrawal reflex of the 
marinesnail Aplysiacalifornica. Following asingle noxious 
stimulus to the tail, the animal acquires a short-term mem- 
ory for the noxious stimulus lasting minutes, during which 
time both the amplitude and the duration of the gill- 
withdrawal reflex to tactile stimulation of the siphon is 
greatly enhanced (Pinsker et al., 1970; Carew et al., 1971). 
Following five or more spaced sensitizing stimuli, the ani- 
mal acquires a long-term memory lasting days or weeks 
(Pinsker et al., 1973). The short-term memory does not 
require new protein synthesis, whereas long-term memory 
is blocked by inhibitors of protein and RNA synthesis 
(Montarolo et al., 1986; Castellucci et al., 1989; Bailey et 
al., 1992). 
A cellular representation of both types of memory stor- 
age can be studied in cocultures consisting of a single 
sensory neuron and a single motor neuron of the gill with- 
drawal reflex. Here one brief application of 5hydroxy- 
tryptamine (5HT, or serotonin), a modulatory transmitter 
released in vivo by interneurons activated by sensitizing 
tail stimuli, produces short-term facilitation that results 
from a strengthening of preexisting synaptic connections 
between the sensory and motor cell by means of covalent 
modifications of preexisting proteins (Montarolo et al., 
1986; Rayport and Schacher, 1986). By contrast, five ap- 
plications of 5HT, spaced by 20 min, produce long-term 
facilitation that lasts for more than one day, is dependent 
on the synthesis of mRNA and protein, and is accompa- 
nied by an increase in the number of sensory neuron syn- 
aptic (terminal) varicosities in contact with the motor neu- 
ron (Montarolo et al., 1986; Glanzman et al., 1990; Bailey 
et al., 1992). 
In cell culture, as in the intact ganglion, both short- and 
long-term facilitation involve an enhancement of transmit- 
ter release induced by CAMP and mediated by the CAMP- 
dependent protein kinase A (PKA) (Brunelli et al., 1976; 
Schachar et al., 1988; Scholz and Byrne, 1988; Ghirardi 
et al., 1992). With repeated pulses of 5-HT, which give 
rise to long-term facilitation, the intracellular CAMP con- 
centration increases (Bernier et al., 1982), and the cata- 
lytic subunit of PKA translocates to the nucleus of the 
sensory neurons (Bacskai et al., 1993), where it appears 
to phosphorylate one or more CAMP response element- 
binding proteins(CREB-like transcription factors), thereby 
activating CAMP-inducible gene expression (Kaang et al., 
1993). Injection of an oligonucleotide containing the so- 
matostatin CAMP response element (CRE) into the nu- 
cleus of a sensory neuron selectively blocks the long-term 
enhancement in synaptic strength induced by 5HT with- 
out affecting the short-term process (Dash et al., 1990). 
We have recently cloned an Aplysia homolog of CREBl 
ApCREBl has 42% homology with the mouse CREBl 
over the whole length of the protein, while the basic re- 
gion-leucine zipper (bZIP) and the phosphorylation do- 
main (P box), characteristic of CREBl, are 96% and 90% 
identical, respectively. Similar to its mammalian ho’mo- 
logs, ApCREBl binds to the CRE in vitro and is a PKA- 
dependent transactivator (Bartsch et al., unpublished 
data). 
In sensory neurons, 5HT and CAMP induce the immedi- 
ate-early gene ApCEBP (encoding the Aplysia CCAAT 
enhancer-binding protein), which encodes a transcription 
factor necessary for the establishment and maintenance 
of the stable, self-maintained structural changes charac- 
teristic of the long-term memory process (Alberini et al., 
1994; Bailey and Chen, 1983; Glanzman et al., 1990). The 
apparent generality of CREBl as a component of the 
switch between short-term and long-term memory in 
Aplysia, Drosophila melanogaster, mice, and perhaps hu- 
mans (Yin et al., 1994, 1995; Bourtchuladze et al., 1994; 
Petrij et al., 1995) encouraged us to explore whether Ap- 
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Figure 1, Amino Acid Sequence of ApCREE2 
(A) The predicted amino acid sequence of ApCREBP deduced from 
two independent clones isolated by a yeast two-hybrid screen of an 
Aplysia CNS cDNA library. The bZlP domain that interacts with Ap- 
ClEBP is boxed and labeled I. Within this domain, hydrophobic resi- 
dues of the leucine zipper motif are shaded. The box labeled II delin- 
eates a second leucine heptad repeat. ApCREB2 contains a consen- 
sus sequence for PKC phosphorylation (amino acids 271-274, bold, 
underlined). In addition, ApCREB2 has putative consensussequences 
for MAP kinase in positions similar to those in human CREBP and 
mouse ATF4 (amino acids 235-238 and amino acids 150-153, italics, 
underlined). This sequence and the ApCREi32 cDNA sequence were 
deposited in GenBank. 
(B) The C-terminal 79 amino acids of ApCREB2 containing the bZlP 
domain aligned with the bZlP domains of mouse ATF4 (mATF-4) and 
human CREBP (hCREB-2). The numbers on the left margin refer to 
the adjacent amino acids, and an asterisk marks the hydrophobic resi- 
dues of the leucine zippers. Identical residues are boxed. Within the 
bZlP region, the compared proteins are 50% identical. A cysteine 
residue in the basic region conserved in most bZlP proteins is substi- 
tuted for a tyrosine at position 323 (shaded). This substitution, as well 
as the tyrosine at position 361 (shaded) within the leucine zipper, is 
conserved among all three proteins: ApCREB2, hCREB2, and mATF4. 
CREBI and ApClEBP can recruit additional transcription 
factors in the sensory neurons following sensitizing 
stimuli. 
Results 
Cloning of ApCREB2 by Its Interaction with ApClEBP 
in the Yeast Two-Hybrid System 
The C-terminal portion of ApClEBP containing the bZlP 
domain was used to screen an Aplysia central nervous 
system (CNS)-specific cDNA library by the yeast two- 
hybrid system (Fields and Song, 1989; Chien et al., 1991). 
Two independent clonescontained an identical open read- 
ing frame of 1134 bp encoding a putative polypeptide of 
378 amino acids (Figure 1A). The 118 C-terminal amino 
acids (amino acids 280-378) of the predicted polypeptide 
contain a bZlP motif (Landschulz et al., 1988; Vinson et 
al., 1989) that interacts with ApClEBP (see Figure 6C). In 
addition to interacting with ApCIEBP, both the full-length 
378 amino acid protein and the C-terminal 118 amino acid 
peptide interact with mammalian CREBl and c-Fos pro- 
teins in the two-hybrid system. 
The predicted polypeptide shows highest sequence ho- 
mology to the amino acid sequences of two transcription 
factors: human CREEP (hCREB2) (Karpinski et al., 1992; 
also known as ATF4 or TAXREB 67 [Hai et al., 1989; Tsuji- 
moto et al., 19911) and mouse ATF4 (mATF4) (Mielnicki 
and Pruitt, 1991; also known as C/ATF [Vallejo et al., 
19931). Therefore, the Aplysia polypeptide has been 
termed ApCREB2. Over the whole length of the protein, 
ApCREB2 shares21 O/o identical amino acids with hCREB2 
and mATF4. In the bZlP domain, ApCREBP, mATF4, and 
hCREB2 are 50% identical (Figure 16). Unlike hCREB2 
or mATF4, ApCREB2 contains a second heptad repeat of 
hydrophobic amino acids near the N-terminus (amino 
acids 73-108) which could potentially form a second leu- 
tine repeat (Figure 1A). However, this domain does not 
mediate ApCREBP homodimerization or the interaction 
with the bZlP domain of ApClEBP (see Figure 6C). 
ApCREB2 Is Expressed in the Nervous System 
of Aplysia 
ApCREB2 mRNA is expressed at high levels in the CNS 
and the gill, but is detectable at low levels by Northern 
blot in all Aplysia tissues tested (Figure 2A). This relatively 
restricted expression of ApCR.532 mRNA contrasts with 
the more ubiquitous expression of its closest homologs, 
mATF4 and hCREB2 (Tsujimoto et al., 1991; Chevray and 
Nathans, 1992; Vallejo et al., 1993; Jungling et al., 1994). 
In Western blots of Aplysia CNS extracts, polyclonal 
ApCREBP antiserum raised against full-length recombi- 
nant ApCREB2 and the affinity-purified anti-ApCREBP an- 
tibody recognize a protein that migrates as multiple bands 
with an apparent molecular weight of around 50 kDa (Fig- 
ures 2B and 2C). This molecular weight is higher than 
the 42 kDa deduced from the ApCREB2 cDNA, but it is 
consistent with the apparent molecular weight of in vitro 
translated ApCREB2 and ApCREBP immunoprecipitated 
from extracts of the Aplysia nervous system (Figure 2C). 
Although both the preimmune antisera and the anti- 
ApCREBP antisera recognize additional proteins in West- 
ern blots of Aplysia CNS extracts, the major 50 kDa signals 
are not detected by the preimmune serum (Figure 2B, 
lane 2), or by the ApCREBP antiserum preincubated with 
recombinant ApCREBP (Figure 2B, lane 3). The strong 
signal at 40 kDa and several weaker signals are recog- 
nized by immune, blocked immune, and preimmune anti- 
sera. Therefore, we have used the preimmune sera and 
the blocked immune antisera as matching controls in elec- 
trophysiological experiments described below. 
ApCREB2 Is Constitutively Expressed 
in Sensory Neurons 
To determine whether ApCREB2 is expressed in the neu- 
rons that exhibit long-term presynaptic facilitation, we 
used reverse transcription-polymerase chain reaction 
(RT-PCR) to examine the expression of ApCRfBP mRNA 
in cultures of Aplysia sensory neurons. We detected Ap- 
CREBP mRNA both in nontreated cultures of sensory neu- 
rons and in cultures exposed to repeated pulses of 5-HT 
(Figure 3A). We also detected ApCREi37 mRNA in un- 
treated Aplysia sensory neurons by RT-PCR (D. B. et al., 
unpublished data). In addition, the steady-state levels of 
ApCREBP and ApCRR37 mRNAs are not affected either 
in vivo or in vitro by exposure to 5-HT, which induces the 
mRNA level of ApCEBP (Figure 38). Furthermore, the 
level of ApCRfBP mRNA does not change following 
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Figure 2. Expression of ApCREB2 in Aplysia Tissues 
(A) Northern blot analysis of ApCRf62 mRNA expression. The tissue 
used as the source of RNA is indicated above each lane. Total RNA 
(5 ug) was loaded in each lane. The arrowhead indicates the position of 
ApCRfBP mRNA detected by hybridization with a full-length ApCRfBP 
cDNA probe (top) and Aplysia actin cDNA probe (bottom). ApCfL332 
mRNA is highly expressed in CNS and gill. 
(B) Western blot analysis of bacterially expressed recombinant Ap- 
CREB2 (top) and Aplysia CNS protein extract (bottom). Recombinant 
ApCREBP (2 Kg) or total protein isolated from AplysiaCNS (15 pg) was 
separated by SDS-PAGE, electroblotted, and probed with antiserum 
raised against recombinant ApCREB2 (immune), preimmune serum, 
and immune ApCREB2 antiserum preincubated with immobilized im- 
munizingApCREB2 antigen (depleted immune). Multiple bands recog- 
nized by the anti-ApCREB2 antibodies, indicated by arrowhead, are 
specifically blocked by depleting the immune serum with recombinant 
ApCREBP. Positions of molecular mass markers, in kilodaltons, are 
indicated. 
(C) Analysis of ApCREBP protein expression in Aplysia CNS by use 
of affinity-purified antibodies. The specific ApCREBP signals are indi- 
cated by arrowheads. 
(IVT) [%]methionine-labeled ApCREB2 protein that has been in vitro 
translated in rabbit reticulocyte lysate, separated by SDS-PAGE, and 
visualized by fluorography. 
pulses 0 1 5 0 1 5 M(r) 
ApCREB-2 * 
B 
5HT in viva 
(min) 0 5 15 30 60 
ApCREB-2 c- 
ApCREB-1 b 
ApC/EBP+ 
Figure 3. ApCREBP Is Constitutively Expressed in the Sensory Neu- 
rons of Aplysia 
(A) ApCfffB2 cDNA, 450 bp, amplified by RT-PCR from Aplysia sen- 
sory neurons. RNA was isolated from cultures of approximately 200 
Aplysia sensory neurons that had been exposed to zero, one, or five 
pulses of 5-HT (10 KM) as indicated. As a control, one half of the RNA 
was processed with reverse transcriptase omitted from the reaction 
(minus RT). ApCRfB2 RNA is constitutively expressed in Aplysia sen- 
sory neurons. 
(B) Northern blot analysis of RNA isolated from CNS of Aplysiaexposed 
to 5-HT in viva. CNSs were dissected from anesthetized animals after 
exposing them in vivo to 5-HT (50 pM) for the time indicated above 
each lane. Total RNA (8 vg) from each timepoint was separated in a 
1% agarose gel, blotted, and consecutively hybridized with probes 
specific for ApCRfB2, ApCRfB7, ApC/fBP, and ribosomal protein S4 
transcripts. 
UnlikeApC/fBPmRNA,ApCRfB2andApCRfBimRNAsareconstitu- 
tively expressed in the Aplysia CNS, and their steady-state level is 
not affected by exposure to 5-HT in viva. 
exposure to agents that increase CAMP (forskolin, isobu- 
tylmethylxanthine, 8-bromo-CAMP, and Sp-CAMPS), ap- 
plication of the PKA inhibitor Rp-CAMPS, calcium ionto- 
phore A23187, phorbol esters, okadaic acid, the protein 
synthesis inhibitor anisomycin, or neuronal injury (data not 
shown). These results indicate that ApCREB2 and Ap- 
CREBl are coexpressed in sensory neurons and that the 
steady-state level of ApXfBP mRNA is not regulated by 
5HT or by the levels of CAMP or cytoplasmic Ca2+. 
ApCREB2 Is a Substrate for Protein Kinases 
The primary structure of ApCREB2 has putative phosphor- 
ylation sites for both PKC and MAP kinases (see Figure 
(W) Western blot of Aplysia CNS protein extract from animals exposed 
to5-HTinvivofor2 hr. Total CNSextract (20 pg) was subjected to SDS- 
PAGE, electroblotted, and probed with affinity-purified anti-ApCREBP 
antibodies. 
(IP) Immunoprecipitation, using affinity-purified anti-ApCREB2 anti- 
bodies, from total Aplysia CNS dissected from anesthetized animals 
and metabolically labeled with [%]methionine. 
ApCREBP is expressed in the Aplysia CNS and migrates on SDS- 
polyacrylamide gels as multiple bands with apparent molecular 
weights of around 50 kDa. 
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Figure 4. ApCREB2 Is a Phosphoprotein In Vivo 
(A) Western blot of Aplysia. CNS extracts from animals were exposed 
to 5-HT in vivo for the time indicated above each lane. The blots were 
probed with anti-ApCREB2, anti-rat CREBl, and anti-ApCIEBP anti- 
bodies. The positions of these proteins are indicated by arrowheads. 
ApCREB2 migrates as multiple bands. Note the appearance of a 
slower-migrating ApCREBP-specific signal in the course of 5HT expo- 
sure. 
(B) Western blot of Aplysia CNS extract from animals exposed to 5-HT 
in vivo for 90 min and incubated with phosphatase (CIP) or mock 
treated (M). The positions of ApCREBS-specific signals are indicated 
by arrows. Note the appearance of a faster-migrating ApCREBP in 
SDS-PAGE after phosphatase treatment. 
These data indicate that ApCREB2 is a phosphoprotein in vivo and that 
the phosphorylation level of ApCREB2 changes following exposure to 
5-HT. 
1A). Furthermore, ApCREB2 is a substrate for PKC, MAP 
kinase, PKA, and CaM kinases in vitro. The phosphoryla- 
tion of ApCREB2 in vitro results in an increase of apparent 
molecular weight of the phosphoprotein in SDS gels (data 
not shown). A similar shift in molecular weight is detected 
by Western blots of Aplysia CNS extracts isolated from 
animals exposed to 5-HT in vivo. Exposure to 5-HT does 
not affect the protein level of ApCREB2 or ApCREBl in 
the Aplysia CNS. By contrast, in the same CNS extracts, 
ApClEBP protein only becomes detectable in vivo after 60 
min of exposure to 5HT (Figure 4A). The shift in apparent 
molecular weight of ApCREB2 following 5-HT treatment 
in vivo presumably is the result of phosphorylation, since 
treatment of the CNS extract with phosphatase results in 
the increased migration of ApCREB2 in SDS-polyacryl- 
amide gels (Figure 48). 
ApCREB2 Is a Repressor of ApCREBl-Mediated 
Activation in F9 Cells 
Human CREBP represses CREBl-mediated transcrip- 
tional activation in CV-1 cells and neurons (Karpinski et 
al., 1992; Jungling et al., 1994). We examined whether 
ApCREB2 could also function as a repressor of ApCREBl- 
mediated transactivation in transfected undifferentiated 
mouse F9 cells. We first examined the ability of ApCREBP 
and ApCREBi to regulate a minimal control region (a sin- 
gle CRE in front of a minimal SV40 promoter) of a pGL3- 
CRE luciferase reporter gene. ApCREBl activates this 
minimal CRE reporter in a PKA-dependent manner (rela- 
tive activation [luciferase activity normalized to 8-galac- 
tosidase activity], 2.13 + 0.26 without and 10.50 f 1.42 
with PKA) and is repressed by ApCREB2 upon cotransfec- 
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Figure 5. Effect of ApCREBP and ApCREBl Expression on CRE- 
Mediated Transcription in F9 Cells 
(A) Mouse F9 cells were transiently cotransfected with 1 ug of pGL3- 
CRE reporter plasmid along with 1 ug of each of the indicated expres- 
sion plasmids. ApCREB2, pRcRSV-ApCREB2; ApCREBl, pRcRSV- 
ApCREBl ; PKA, pRcRSV-PKA. All transfections were adjusted to 4 ug 
of total DNA with pRcRSV vector DNA. The luciferase activity of the 
reporter was normalized to j3-galactosidase activity from 0.2 ug of the 
cotransfected RSV-IacZ expression plasmid. The relative luciferase 
activity was calculated by comparing the activities measured in 
cotransfection experiments to the activity of pGL3CRE alone (arbi- 
trarily set at 1.0). Each bar represents the mean of at least nine inde- 
pendent transfections + SEM. 
ApCREB2 does not activate transcription on its own, but represses 
the activation mediated byApCREB1 on a minimal CRE control region. 
(8) Transient transfections of F9 cells with a 5 x CRE-VIP-IacZ reporter 
plasmid. The indicated expression constructs were cotransfected with 
5x CRE-VIP-IacZ reporter as in (A), except that relative j3-galac- 
tosidase activity was calculated relative to 5 x CRE-VIP-IacZ reporter 
and normalized to the luciferase activity of cotransfected pRSV-luc. 
ApCREB2 and ApCREBl are activators of 5 x CRE-VIP-IacZ reporter, 
but become mutual repressors when coexpressed. 
tion in the absence and presence of PKA catalytic subunit 
(relative activation, 0.96 f 0.15 and 1.64 f 0.20, respec- 
tively) (Figure 5A). The degree of ApCREBl repression by 
ApCREB2 is dependent on the concentration of ApCREB2 
(data not shown). ApCREB2 does not activate this minimal 
CRE reporter. 
In previous experiments, Kaang et al. (1993) demon- 
strated that a 5 x CRE-VIP-laci! reporter is activated by 
5-HT and CAMP in Aplysia sensory neurons. We therefore 
also cotransfected ApCREB2 and ApCREBl with this re- 
porter. Upon cotransfection, ApCREBP again abolished 
the transcriptional activity of ApCREBl both in the ab- 
sence and in the presence of PKA (relative activation, 
1.84 +- 0.25 and 4.12 -c 0.53, respectively, as compared 
with 2.13 k 0.30 and 48.60 f 5.23 for ApCREBl alone) 
(Figure 58). Similarly, ApCREB2 repressed transactiva- 
tion mediated by rat CREBl (relative activation, 2.27 f 
0.3 and 5.15 f 0.62, as compared with 7.65 + 0.65 and 
68.82 f 7.3 for rat CREBl alone, without and with PKA, 
respectively). 
Thus, our data suggest that ApCREBP can repress both 
ApCREBl and rat CREBl -mediated transactivation from a 
CRE and are consistent with the possibility that ApCREB2 
and ApCREBl may interact directly on the CRE. 
ApCREB2 Can Be an Activator in the Absence 
of ApCREBl 
In addition to repressing transcription mediated by Ap- 
CREBl, we found that ApCREB2 can also function as an 
activator of the 5 x CRE-VIP-IacZ reporter gene in F9 cells. 
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Figure 6. ApCREBP Homodimers Bind to CRE 
(A) The sequence of DNA-binding sites for ApCREB2 (BSI) and ApCl 
EBP (BS2). Optimal DNA-binding sequences were selected from a 
pool of double-stranded random 20-mers by repeated binding and PCR 
amplification. In both BSl and BS2, the homology to the CAAT box 
is underlined, and the homology to the palindromic CRE site (above) 
is in boldface. 
(B) Specificity of recombinant Hiss-ApCREBP binding to symmetrical 
and asymmetrical CREs and CAAT-binding sequences. EMSA with 
double-stranded oligonucleotides containing the CREs of the somato- 
statingene(l)and itscorepalindrome(2),PfPCKgene(3), proenkeph- 
alin gene (4) and putative CRE of the ApC/EBP gene (5). Also tested 
were the BSl-selected ApCREB2 DNA-binding sequence (6) a com- 
posite CRE-CAAT-binding site (7), the CIEBP-binding APRE of the 
angiotensin gene (8) the selected 852 ApClEBP DNA-binding site (9), 
and the CIEBP-binding ERE of the fos promoter (10). The arrowhead 
indicates the position of a specific ApCREB2 shift, and an asterisk 
marks the unbound oligonucleotide probes. The specrfrcrtres of the 
shifts were confirmed by competition with 10 and 100 molar excess 
of nonradioactive oligonucleotides and mutants of the CRE and ClEBP 
sites (data not shown). Recombinant ApCREBP binds directly to the 
high-affinity somatostatin CRE as well as to BSl and the CRE from 
the proenkephalin gene, but does not bind to any of the CAAT sites 
tested. 
(C) Interaction of in vitro translated ApCREBP and ApClEBP with bacte- 
rially expressed glutathione S-transferase (GST) fusions of ApCREB2. 
ApCREB2 transactivation in F9 cells is stimulated by PKA 
to a level comparable to that of ApCREBl (relative activa- 
tion, 2.46 + 0.2 without and 43.12 f 5.1 with PKA) (Figure 
5B). Both the full-length ApCREB2 protein and its N-ter- 
minal 288 amino acids are strong activators of the reporter 
UASJacZ gene when fused to the GAL4 DNA-binding 
domain (relative activity, 82% f 27% and 59% + 18%, 
respectively, as compared with wild-type GAL4). Thus, Ap- 
CREB2 has an internal transcription activation domain in 
its N-terminal 288 amino acids and can under certain cir- 
cumstances be a transcriptional activator. Unlike Ap- 
CREBl, ApCREB2 cannot activate a minimal, single-copy 
CRE-driven construct (Figure 5A). Thus, the activating and 
repressing potential of ApCREB2 and ApCREBl on the 
CRE are not fully symmetrical. The ability of ApCREB2 to 
activate from the CRE is more restricted than its ability to 
repress ApCREBl. 
ApCREBP Is a ME-Binding Protein 
We examined the DNA binding specificity of ApCREB2 in 
a binding site selection assay using bacterially expressed 
recombinant ApCREB2 protein to select optimal binding 
sequences from a pool of randomly generated DNA tar- 
gets. This assay identified a binding sequence (BSl) for 
ApCREBP that resembles the CRE DNA-binding se- 
quence of the CREBlCREMlATF family of transcription 
factors (the CAMP response element-binding proteins, 
CAMP response element modulators, and activating tran- 
scription factors), as well as the CAAT DNA-binding motif 
of the ClEBP family of transcription factors (Figure 6A). 
We then reexamined the DNA binding capability of Ap- 
CREBP by electrophoretic DNA mobility shift assays 
(EMSAs) using both symmetrical and asymmetrical CREs 
and CAAT motifs of CIEBP-binding sites. Purified bacteri- 
ally expressed ApCREB2 protein binds in solution thesym- 
metrical CRE of the somatostatin gene, the core CRE pal- 
indrome, the asymmetrical CRE of the enkephalin gene, 
and the BSl DNA-binding site. However, ApCREBP did 
not bind to the asymmetrical CRE of the phosphoenolpyr- 
uvate carboxykinase (PfPCK) gene or to the asymmetrical 
putative CRE site of the ApClEBP gene. In addition, Ap- 
CREB2 did not bind to any of the CAAT DNA-binding sites 
tested (Figure 6B). 
The binding affinity of ApCREB2 to CRE was low, per- 
haps because of inefficient homodimer formation. Delet- 
ing the 260 N-terminal amino acids of ApCREB2, which 
removes the second leucine repeat motif, greatly in- 
creases the efficiency of homodimer formation. This dele- 
tion does not affect heterodimer formation, as both the 
full-length and the N-terminal deletion mutant ofApCREB2 
heterodimerize with the same high affinity with ApClEBP 
(Figure 6C). We therefore conclude that ApCREB2 forms 
Glutathione-agarose beads saturated with equal amounts of bacteri- 
ally expressed GST-ApCREB2 and its deletion mutants (indicated 
above lanes) were incubated with 35S-labeled ApCREB2 or ApClEBP 
proteins and washed, and eluted bound proteins were resolved by 
SDS-PAGE. ApCREB2 forms weak homodimers, but that homodimer 
formation can be greatly increased by deleting the N-terminal 260 
amino acids, which contain the second leucine repeat. 
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tures. Changes in EPSP amplitude after appli- 
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,Orn” This long-term facilitation is abolished by the 
50 “7s application, during training, of the protein syn- 
thesis inhibitor anisomycin (1 x 5-HT plus CREBP Ab plus ANISO) or the RNA synthesis inhibitor actinomycin D (1 x 5HT plus CREBP Ab plus 
ACTINO). The difference in EPSP amplitude at 2 hr between five pulses of 5-HT and one pulse of 5-HT plus CREEP Ab may reflect the transient 
protein synthesis-dependent but RNAsynthesis-independent component of long-term facilitation 2 hr after 5-HT stimulation (Ghirardi et al., 1995). 
The controls are either untreated (control), or injected with ApCREB2 antiserum without exposure to 5-HT (CREE2 Ab). 
(B) Comparison of the time course of the EPSP amplitude changes in the first 2 hr after application of a single 5 min pulse of 5-HT with or without 
injection of CREBP Ab. The control cells were not exposed to 5-HT. 
(C) Example of EPSPs recorded in motoneuron L7 after stimulation of the sensory neuron before (0 hr), 2 hr after, and 24 hr after 5-HT treatment. 
One pulse of 5-HT paired with the injection of an ApCREB2 antiserum induces a significant increase in EPSP amplitude at 2 and 24 hr, but injection 
with the preimmune serum (PRE-CREBP Ab) or depleted immune serum does not induce long-term facilitation. 
(D) Examples of EPSPs recorded at indicated times in cocultures injected with ApCREBP antiserum paired with one 5 min pulse of 5-HT. 
weak homodimers on the CRE, perhaps owing to the pres- 
ence of an inhibitory structure in the N-terminal part of 
the protein. In contrast with its ability to form only weak 
homodimers, we have found that ApCREBP can effectively 
heterodimerize with other bZlP transcription factors. In 
preliminary experiments, we find that in addition to ApCI 
EBP, ApCREB2 forms in vitro heterodimers with Ap- 
CREBl, with rat CREBl, and with c-Fos proteins. 
One Pulse of 5HT Produces Long-Term Facilitation 
When Paired with Injection of ApCREB2 Antiserum 
In both the intact Aplysia and in dissociated cell culture, 
five pulses of 5-HT induce long-term facilitation in the con- 
nections between the sensory and motor neurons lasting 
more than 24 hr. By contrast, a single pulse of 5HT pro- 
duces only a short-term facilitation lasting about 10 min 
(Figures 7A and 78). This single pulse increases the excit- 
atory postsynaptic potential (EPSP) evoked in the motor 
cell by stimulating a single sensory neuron by 76.7% at 
1 min after 5HT exposure (+ 5.4%, n = 11, p < 0.01 
compared with control cells). This facilitation decays to 
13.6% at 10 min (k 18.7%, n = 5) and to 2.83% at 30 
min ( f 8.80/o, n = 12). By 2 hr after a single pulse of 5-HT, 
the change in EPSP amplitude has returned to control level 
(-1.0% f 5.7%, n = 16) and it remains there at 24 hr 
(-4.12% + 6.09%, n = 8). 
To determine whether ApCREB2 could also act as a 
functional repressor and parallel its action as a transcrip- 
tional repressor of ApCREBl in transfection assays, we 
injected ApCREB2 antiserum into the sensory neurons 
1 hr before exposure to single or multiple pulses of 5-HT. 
In the presence of the antiserum, rather than producing 
the short-term facilitation lasting 10 min, one pulse of sero- 
tonin produced facilitation lasting more than 24 hr. This 
facilitation was robust; it was seen in 42 out of 43 cells. 
Moreover, the facilitation seen at 24 hr was comparable 
in magnitude to that seen at 24 hr with five pulses of 5-HT. 
The long-term facilitation following five pulses of 5HT 
is seen as early as 2 hr after the first pulse (Figure 7A; 
Ghirardi et al., 1995). This early component of long-term 
facilitation has a larger amplitude than the facilitation evi- 
dent at 24 hr, but it differs mechanistically from the facilita- 
tion evident at 24 hr in that it is only partially (about 70%) 
dependent on RNA synthesis, although it is completely 
dependent on protein synthesis. When a single pulse of 
5-HT is paired with the injection of ApCREBP antiserum, 
there is also a significant facilitation present at 2 hr 
(+100.95% [f 12.52%, n = 43, p< O.Ol]), and thisfacili- 
tation persists 24 hr later, when the synaptic potential is 
still significantly facilitated (+70.05% [ f 7.65%, n = 42, 
p < O.Ol]; Figures 7A, 8A, and 8B). By contrast, cultures 
treated with one pulse of 5-HT and injected with serum 
depleted of anti-ApCREB2 antibody or with preimmune 
serum show no significant facilitation, either at 2 hr 
(+19.640/o f 10.56%, n = 11 and +13.75% + 4.050/o, 
n = 12, respectively), or at 24 hr (-4.27% -+ 9.70%, n = 
11 and +1.50% f 11.570/o, n = 12, respectively) com- 
pared with the noninjected control cells not exposed to 
5-HT (-6.21% f 2.10%, n = 14 at 2 hr, and -0.33% f 
4.56%, n = 9 at 24 hr) (Figures 8A and 88). As an addi- 
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C Figure 8. Summary of the Effectsof Injection of 
ApCFtEB2 Antiserum on Short- and Long-Term 
Facilitation 
(A) Facilitation 2 hr after one pulse of 5-HT. 
Injection of ApCREBP antiserum paired with 
one pulse of 5-HT induces a facilitation at 2 hr 
that is blocked by anisomycin (ANISO) and acti- 
nomycin D (ACTINO). The height of each bar 
corresponds to the mean percentage change 
* SEM in EPSP amplitude tested 2 hr after 
one pulse of 5-HT or of seawater (control cul- 
tures, first bar). CREBP and ClEBP indicate 
antisera raised against recombinant ApCREBP 
and ApClEBP proteins, respectively. CREB2 
depleted indicates the immune anti-ApCREB2 
serum depleted by incubation with bacterially 
expressed ApCREB2 bound to agarose beads. 
PRE indicates matching preimmune serum. 
PAS is an antiserum raised against an Aplysia 
RNA-bindingY box protein (Skehel and Bartsch, 
1994). 
(B) Long-term facilitation 24 hr after one pulse 
of 5-HT. The facilitation induced by one pulse of 
5HT paired with ApCREB2 antiserum injection 
lasts 24 hr and is dependent on RNA and pro- 
tein synthesis. The height of each bar corre- 
sponds to the mean percentage change f SEM in EPSP amplitude tested 24 hr after one 5 min pulse of 5HT or of seawater (control cultures, 
first bar). 
(C) Long-term facilitation 24 hr after five pulses of 5-HT. Long-term facilitation induced by five pulses of 5-HT is not affected by ApCREB2 antiserum 
injection. The height of each bar corresponds to the mean percentage change f SEM in EPSP amplitude tested 24 hr after five 5 min pulses 
of 5-HT or of seawater (control cultures, first 3 bars). The injection of ApCREBP antiserum (third bar) as well as injection of normal rabbit serum 
(NRS, second bar) without exposure to 5HT does not induce long-term facilitation. 
(D) Short-term facilitation is not affected by injection of ApCREBP antiserum. The height of each bar corresponds to the mean percentage change 
f SEM in EPSP amplitude tested 1 min after one pulse of 5-HT or of sea water (control cultures, first bar). 
tional control, we paired a single pulse of 5-HT with the 
injection of two unrelated antibodies (anti-ApCIEBP Ab, 
anti-PAS Ab). In both cases, we found no significant facili- 
tation either at 2 hr (+11.8% + 5.51%, n = 5 and 
+1.87% f 6.29%, n = 8, respectively) or at 24 hr 
(+1.80/o + 9.77%, n = 5, and +3.620/o * 11.97%, n = 
8, respectively) (Figures 8A and 88). These results were 
obtained with a single ApCREBP antiserum. However, in- 
jection of a second independently raised ApCREB2 antise- 
rum yielded comparable results (data not shown). 
Facilitation Produced by One Pulse of 5-HT Paired 
with Injection of ApCREB2 Antiserum Has the 
Properties of Transcriptionally Dependent 
Long-Term Facilitation 
Long-term facilitation induced by repeated pulses of 5-HT 
requires protein and RNA synthesis (Montarolo et al., 
1986; Bailey et al., 1992). We therefore examined the ef- 
fect of the protein synthesis inhibitor anisomycin and the 
RNA synthesis inhibitor actinomycin D on the synaptic 
modifications produced at 2 hr and 24 hr after the injection 
of ApCREB2 antiserum paired with the application of a 
single pulse of 5HT. Incubating sensory-motor neuron 
cocultures with anisomycin during a single pulse of 5HT 
blocks the increase in amplitude of synaptic potential after 
injection with ApCREBP antiserum, both at 2 hr after expo- 
sure(+19.17% f 6.85%,n = 18)andat24hr(+3.67% f 
5.54%, n = 18) (Figures 7A, 8A, and 88). Similar results 
were obtained with actinomycin D, where the facilitation 
at 2 hr was reduced to +10.120/o (+: 5.10%, n = 24), and 
at 24 hr to 7.87% (k 5.840/o, n = 24) (Figures 7A, 8A, 
and 8B). 
If, in the presence of ApCREBP antiserum, one pulse 
of 5-HT phenocopies long-term facilitation, the injection 
of antibody should not be able to enhance further the ef- 
fects of five pulses of 5-HT. In the cocultures injected with 
ApCREBP antiserum, the facilitation measured 24 hr after 
five pulses of 5-HT was not significantly greater 
(+74.5% & 13.56010, n = 20) than the facilitation obtained 
in cells exposed to five pulses of 5-HT and not injected 
with antibody(+79.6% f 12.950/o, n = 15), orcells treated 
with five pulses of 5-HT and injected with normal rabbit 
serum (+91.60/o f 21.31 O/o, n = 10) (Figure 8C). Injection 
of ApCREB2 antiserum alone, without 5-HT treatment, in- 
duced a slight decrease in the strength of the connection 
(-5.11% f 5.030/o, n = 9), similar to that found in the 
control cocultures. In conclusion, the facilitation produced 
by one pulse of serotonin in the presence of the antibody 
has properties similar to that induced by five pulses of 
5-HT and occludes the effect of five pulses. 
The facilitation produced at 2 hr by five pulses of 5-HT 
is completely blocked by inhibitors of protein synthesis, 
but is only partially blocked by inhibitors of transcription 
(Ghirardi et al., 1995). This suggests that five pulses of 
5-HT modulate both transcription and translation. Since 
ApCREBP presumably acts only on the transcriptional 
component of long-term facilitation, one might predict that 
the pairing of one pulse of 5-HT with injection of ApCREB2 
antiserum would produce less facilitation at 2 hr than five 
pulses of 5-HT. The facilitation at 2 hr produced by one 
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pulse of 5-HT in the presence of ApCREBP antibody is 
approximately 30% less than that produced by five pulses 
of 5-HT (see Figure 7A). Similarly, injection of CRE oligo- 
nucleotides, which would also be likely to affect only the 
transcriptional component of 2 hr facilitation, produced a 
comparable inhibition at 2 hrs [EPSP increase to +66.29% 
(+ 18.76%, n = 14)], thus supporting the suggestion that 
the role of ApCREBP is specific to the transcriptional re- 
sponse to 5HT. 
Facilitation Induced by One Pulse of 5-HT Paired 
with Injection of ApCREB2 Antiserum 
Has Two Distinct Phases 
We find that the facilitation induced by one pulse of 5-HT 
paired with injection of ApCREB2 antiserum shows two 
temporal stages: the first phase issimilar both in amplitude 
and time course to the short-term facilitation induced by 
one pulse of 5-HT in the absence of the antibody (see 
Figures 7A and 76). Thus, in the presence of ApCREB2 
antiserum, the facilitation also peaks at 1 min and decays 
at 30 min to 33.30% (f 10.440/o, n = 20), but instead of 
decaying progressively and completely back to baseline 
after 30 min as in uninjected cells, a second phase of 
facilitation emerges. At 1 hr, this facilitation reaches+72% 
( f 19.740/o, n = 1 l), and at 2 hr, it is about +100.95% 
( + 12.520/o, n = 43). This second phase presumably rep- 
resents the gradual emergence of the transcriptional com- 
ponents of long-term facilitation. 
Injection of ApCREB2 Antiserum Does Not Affect 
Short-Term Facilitation 
We next investigated the effect of ApCREB2 antiserum 
injection on short-term facilitation induced by one pulse 
of 5-HT. One minute after exposure to one pulse of 5-HT, 
the noninjected cells showed a facilitation of +79.43% 
( + 7.06%, n = 7), the cells injected with ApCREB2 antise- 
rum showed a facilitation of +96.17% (f 32.350/o, n = 
6), and the cells injected with normal rabbit serum had a 
facilitation of +76.450/o ( f 12.03%, n = 11) (Figure 8D). 
All these values are significantly different from the de- 
crease in EPSP amplitude due to homosynaptic depres- 
sion observed in control cells not exposed to 5-HT 
(-25.5% + 5.590/o, n = 8, p < 0.01). Thus, as with other 
agents that specifically affect the long-term process, Ap- 
CREB2 antiserum has no effect on the short-term process 
(Alberini et al., 1994; Dash et al., 1990). 
One Pulse of 5-HT Paired with Injection of the 
ApCREB2 Antiserum Induces the Growth 
of New Synaptic Connections 
Long-term memory for sensitization of the gill-withdrawal 
reflex is associated with the growth of new synaptic con- 
nections between the sensory neurons and their follower 
motor neurons (Bailey and Chen, 1983, 1988). The dura- 
tion of this structural change parallels the behavioral reten- 
tion of the memory (Bailey and Chen, 1989). Similar 
changes can be observed in sensory-motor neuron cocul- 
tures where five pulses of 5-HT produce a long-lasting (24 
hr) increase in the number of sensory varicosities con- 
tatting the motor neuron (Glanzman et al., 1990; Bailey 
et al., 1992). 
To determine whether ApCREB2 can also act as a re- 
pressor of the morphological changes that accompany 
long-term facilitation, we injected the ApCREB2 antiserum 
into sensory neurons and examined the consequences 
of one pulse of 5-HT on long-term changes both for the 
strength of the sensory-motor neuron connection and for 
the number of fluorescently labeled sensory neuron vari- 
cosities contacting the motor neuron (Figures 9 and,lO). 
The pairing of a single pulse of 5-HT with the injection of 
ApCREB2 antiserum 1 hr before training induced signifi- 
cant increases, evident 24 hr after the injection, in both the 
strength of the sensory-motor neuron connection (66% f 
12%, n = 8, p < 0.001) and the number of sensory neuron 
varicosities contacting the postsynaptic motor neuron 
(59% f 8%, n = 8, p < 0.001). 
By contrast, control cells receiving just one pulse of 
5-HT and no injection of antiserum showed no facilitation 
(-31.5% f 6.0%, n = 6) and no increase in the number 
of sensory neuron varicosities (-100/o f 7%, n = 6) 24 
hr following training (Figure 9). Figure 10 contains exam- 
ples of raw data taken from individual cocultures and illus- 
trates the marked long-term increases in both the ampli- 
tude of the evoked EPSP and the number of fluorescently 
labeled sensory neuron varicosities elicited by one pulse 
of 5-HT in the presence of antibody to ApCREB2. As is the 
case with the structural changes induced by conventional 
long-term training in vitro, using five pulses of 5-HT, the 
application of one pulse of 5-HT paired with injection of 
ApCREBP antiserum now results in the formation of new 
sensory neuron varicosities in contact with the motor neu- 
ron as well as new neuritic outgrowth. The magnitudes of 
both the long-term functional and structural changes are 
Figure 9. Summary of Long-Term Functional and Structural Changes 
Evoked by One Pulse of 5-HT Paired With Injection of ApCREB2 Anti- 
serum 
For the functional changes, the height of each bar is the mean + 
SEM of the percent change in the amplitude of the EPSP induced in 
motor neuron L7 following a single pulse of 5-HT and retested 24 hr 
later. For the structural changes, the height of each bar represents 
the mean f SEM of the percent change in the number of fluorescent 
varicosities per sensory neuron reexamined 24 hr after one pulse of 
5-HT. 
Injection of the ApCREBP antiserum paired with one pulse of 5-HT 
results 24 hr later in a significant enhancement of the EPSP amplitude 
and a concomitant significant increase in the number of varicosities. 
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comparable to those seen at 24 hr following five pulses 
of 5-HT (Glanzman et al., 1990; Bailey et al., 1992). 
Discussion 
We have cloned a bZlP transcription factor, ApCREB2, 
that is homologous to human CREBP (Hai et al., 1989; 
Tsujimoto et al., 1991: Karpinski et al., 1992) and mouse 
ATF4 (Mielnicki and Pruitt, 1991; Vallejo et al., 1993). Ap- 
CREB2 represses the activation mediated by ApCREBl 
in mouse F-9 cells. Following injection into the presynaptic 
sensory neurons of either of the two specific ApCREBP 
antisera, one pulse of 5-HT, which normally induces short- 
term presynaptic facilitation that does not require RNA or 
protein synthesis, produces long-term facilitation that lasts 
more than a day, requires both transcription and transla- 
tion, and is accompanied by a growth of new synaptic 
connections. 
Although the parallel between the inhibition of Ap- 
CREBl-mediated transactivation in the F9 cells and the 
inhibitory action of ApCREBP in the sensory neurons is 
suggestive, the functional repression by ApCREB2 in the 
induction and maintenance of long-term facilitation does 
not necessarily mean it occurs by means of transcriptional 
repression. Since ApCREBP can activate transcription on 
its own, it is conceivable that ApCREB2 may be a repres- 
sor only indirectly and that it functions in sensory neurons 
by activating expression of genes that are themselves in- 
hibitory for the induction of long-term facilitation. Further- 
more, we cannot rule out the possibility that the anti- 
ApCREB2 antibodies activate ApCREBP rather than 
blocking it. Nevertheless, we favor the idea that ApCREB2 
acts as a direct repressor of long-term facilitation. Our data 
so far are most consistent with the idea that the anti- 
ApCREBP antibodies prevent ApCREB2 from interacting 
with transcriptional activators (such as ApCREBl). 
Figure 10. Examples of Structural Changes Ev- 
ident 24 hr after One Pulse of 5-HT Paired with 
Injection of ApCREB2 Antiserum 
The fluorescent micrographs taken from the 
same regions of sensory neurites contacting 
the axon hillock of L7 before (1 and 3) and 24 hr 
after treatment (2 and 4). Arrows in (2) illustrate 
examples of some of the new varicosities pres- 
ent one day after one pulse of 5-HT paired with 
the injection of the ApCREB2 antiserum. By 
contrast, cocultures exposed to one pulse of 
5-HT in the absence of antiserum injection (4) 
showed no long-term increases in either the 
amplitude of the evoked EPSP or in the number 
of sensory neuron varicosities. All micrographs 
are composed of superimpositions of labeled 
sensory neurite images taken from all focal 
planes of the view area. As a result, the shape 
of individual varicosities may be obscured. 
The EPSPs, evoked before (0 hr) and after (24 
hr) one pulse of 5-HT in the pictured neurons 
are indicated in the inserts. 
Scale bar, 20 urn. 
ApCREB2 Resembles Human CREBP in Both 
Sequence and Repression of ApCREBl 
ApCREBP resembles most closely human CREB2 and 
mouse ATM in its primary amino acid sequence and in 
its binding (albeit with low affinity) to the CRE (Hai et al., 
1989; Karpinski et al., 1992). Furthermore, interaction of 
ApCREB2 with ApClEBP resembles the interaction of 
ATF4 and ClEBPf3 (Vallejo et al., 1993). In addition, Ap- 
CREB2 represses ApCREBl-mediated transactivation in 
F9 cells, thus resembling the repression of CREBl by hu- 
man CREB2 (Karpinski et al., 1992; Jungling et al., 1994). 
In fact, ApCREB2 can substitute for human CREBP as a 
repressor of mammalian CREBl in mouse F9 cells. 
The mechanisms whereby ApCREBP mediates tran- 
scriptional repression of ApCREBl are not yet known. 
However, its action seems to be distinct from the known 
inducible and constitutive repressors of CRE-mediated 
transactivation. For example, unlike the inducible repres- 
sors ICER (for inducible CAMP early repressor) or E4BP4 
(Molina et al., 1993; Cowell et al., 1992), ApCREBP is con- 
stitutively expressed and can act as a transcriptional acti- 
vator. This ability to activate transcription also distin- 
guishes ApCREB2 from the constitutive repressors of 
CRE-mediated transactivation exemplified by CREMa, 
CREM8, and CREMr. ApCREB2 also lacks other features 
characteristic of the CREMs, such as the highly conserved 
KID domain (Foulkes and Sassone-Corsi, 1992). 
In Addition to Being a Repressor of ApCREBl, 
ApCREB2 Can Also Be an Activator 
The finding that ApCREB2 can both repress and activate 
transcription further demonstrates that the distinction be- 
tween activators and repressors is not strict but is critically 
dependent on the particular promoter, on the recruitment 
of the specific second messenger pathways, and on the 
repertoire of the transcription factors available (Hai et al., 
1989; Vallejo et al., 1993; Lemaigre et al., 1993; Ellis et al., 
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1995). ApCREB2 is an activator as a GAL4 fusion protein in 
yeast and a PKA-dependent transactivator when cotrans- 
fected with the 5 x CRE-VIP-IacZ reporter gene. However, 
ApCREBP does not activate transcription from the minimal 
CRESV40 regulatory region in the pGL3-CRE reporter 
gene, although it can repress the transactivation by Ap- 
CREBl from this minimal reporter. The reason for this 
difference is not clear. Perhaps for effective transactiva- 
tion, ApCREB2 requires multiple CREs; alternatively, Ap- 
CREB2 may interact with additional regulatory elements 
in the 5 xCRE-VIP-IacZ reporter that are unrelated to 
the CRE. 
Induction of Long-Term Memory Requires 
the Coordinated Regulation of 
B6th CREBl and WEB2 
Our data provide evidence that ApCREB2 is a functional 
repressor of long-term facilitation. These data and the par- 
allel work in Drosophila provide novel molecular evidence 
for a possible role of functional repressors in memory stor- 
age. Overexpression of an inhibitory form of Drosophila 
CREBl, dCREB2-b, blocks the formation of long-term 
memory in transgenic flies (Yin et al., 1994). Recently, 
Yin et al. (1995) demonstrated that overexpressing the 
activating form of Drosophila CREBl (dCREB2-a) greatly 
reduces the number of training trials needed to establish 
long-term memory. This gain of function, where a single 
massed training trial is sufficient to achieve long-term 
memory that normally requires many spaced training tri- 
als, greatly strengthens the earlier evidence from Dro- 
sophila (Yin et al., 1994, 1995), Aplysia (Dash et al., 1990; 
Kaang et al., 1993), and mice (Bourtchuladze et al., 1994) 
that CREBl is of central importance in initiating the long- 
term memory formation. 
The results in Aplysia point to a parallel importance for 
ApCREBP in this process. Injection of anti-ApCREB2 anti- 
bodies paired with a single training trial, which normally 
produces only short-term facilitation, results in induction 
of long-term facilitation. This gain of function resembles 
overexpression of the dCREB2-a activator in Drosophila. 
These findings suggest the interesting possibility that re- 
moval of the ApCREBBmediated repression may be lim- 
iting in regulating the long-term increase in synaptic 
strength. 
A Possible Mechanism for the Physiological 
Role of ApCREB2 
There are a number of ways by which a transcription factor 
such as ApCREBP could serve as a direct repressor (for 
recent review, see Johnson, 1995). First, ApCREB2 could 
act directly to inhibit the basal transcriptional machinery. 
Since ApCREB2 can be an activator on its own, we think 
this unlikely. Second, ApCREB2 could compete for the 
DNA-binding sequence with ApCREBl (or another activa- 
tor). Since the affinity of the ApCREBP homodimers for 
CRE is much lower than that of ApCREBl, we also think 
this unlikely. We therefore favor the possibility that Ap- 
CREB2 might mediate repression by interacting directly 
with ApCREBl (or another activator) to form an inactive 
heterodimer. Both ApCREBl and ApCREB2 are coex- 
pressed in the sensory neurons. Moreover, ApCREB2 can 
form heterodimers on a CRE with rat CREBl in vitro. How- 
ever, it remains to be determined whether ApCREB2 also 
heterodimerizes with ApCREBl in vivo. 
How might the repression of ApCREBl byApCREB2 be 
relieved? Since we do not detect a change in the amount of 
the ApCREB2 protein after exposure to 5-HT, the relief of 
repression most likely does not involve targeted degrada- 
tion of the ApCREB2 protein. More likely the repressive 
action of ApCREBP is relieved by a covalent modification 
induced by the repeated pulses of 5-HT. According to this 
view, the physiological role of ApCREB2 may be twofold: 
first, it may prevent the long-term process from being 
turned on adventitiously without repeated exposures to 
5HT; second, it may regulate the amplitude of synaptic 
change by integrating the activation of ApCREBl by PKA 
with signals from additional second messenger pathways. 
The induction of long-term facilitation and the concomi- 
tant structural changes induced by a single pulse of 5-HT 
paired with injection of anti ApCREBP antibody is consis- 
tent with the idea that a single pulse of 5-HT is sufficient 
to induce the activating pathway fully. The finding that 
ApCREB2 transcriptionally represses ApCREBl in the 
presence of cotransfected catalytic subunit of PKA in F9 
cells indicates that another pathway besides PKA (a path- 
way not active in undifferentiated F9 cells) must mediate 
its derepression. This suggests the interesting possibility 
that additional second messengers and kinases or phos- 
phatases may be involved in relieving the repression. 
The pathways regulating stimulation of the activator and 
relief of the repressor may have distinctive kinetics. Such 
differences in kinetics could define the optimal time win- 
dow separating training trials and account for the well- 
established difference between massed and spaced train- 
ing (Carew et al., 1972; Pinsker et al., 1973; Yin et al., 
1994,1995). In cell culture, as in the intact animal, spaced 
training (five pulses of 5-HT separated by 20 min) is more 
effective in triggering long-term facilitation than massed 
training (five pulses of 5-HT not separated at all but given 
continuously over 25 min). The synaptic potential mea- 
sured 24 hr after training is facilitated by +80% 
( f 12.95%, n = 15) after five spaced pulses as compared 
with only +39% (* 19%, n = 16) after 25 minutes of 
continuous exposure to 5-HT. Perhaps the reason that 
spaced training is more effective than massed training is 
that only spaced training allows coordinated activation of 
ApCREBl and derepression of ApCREB2. 
That 5HT triggers different signaling pathways in a co- 
ordinated way, PKA to stimulate the activator and possibly 
other signaling pathways to relieve the repressor, should 
not be taken to indicate that each of these pathways can- 
not be engaged alone by transmitter signals other than 
5HT, acting on surface receptors. Certain modulatory 
transmitters might act selectively to relieve repression. 
Such a priming action on memory might allow for one trial 
learning. 
One Trial Learning: Flashbulb Memories 
Dual control of activators and repressors by different sec- 
ond messenger pathways could provide a beginning in- 
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sight into a range of features characteristic of memory, 
ranging from amnesia to photographic memory. For exam- 
ple, a characteristic feature of age-related memory loss 
(benign senescent forgetfulness) is the inability to consoli- 
date long-term memories (Petersen et al., 1992). This 
aging defect, therefore, may represent not only a weaken- 
ing stimulation by activators, but perhaps also an inability 
to relieve repression. Conversely, genetically endowed dif- 
ferences in the activity of the repressor in relation to the 
activator could prime the storage process and contribute 
to exceptional memory. Although long-term memory typi- 
cally requires repeated spaced training, it occasionally oc- 
curs following a single exposure. One trial learning is par- 
ticularly well developed in certain rare individuals 
(memorists) with exceptional memory. For example, the 
famous memorist D. C. Shershevski, studied by A. R. Luria 
(1968), seemed never to forget anything he had learned 
following a single exposure, even after more than a de- 
cade. More commonly, memorists have more restricted 
capabilities: they may be exceptionally good in remember- 
ing certain specific types of knowledge and not others 
(Brown and Deffenbacher, 1995). There are people with 
astonishing memory that is selective for visual images, for 
musical scores, for chess games, for poetry, or for faces. 
For example, the Shass Pollaks, the Talmudic memorists 
from Poland, have the ability to recall, from visual memory, 
every word on every page of the twelve volumes of the 
Babylonian Talmud as if that one page (out of several 
thousand pages) were in front of their eyes (Stratton, 
1917). 
But photographic memory is not limited to memorists. 
The most common type of photographic memory, flash- 
bulb memory, is a detailed and vivid memory most people 
store on one or another occasion and retain for a lifetime 
(Brown and Kulik, 1977; Conway, 1995; Neisser, 1982). 
Flashbulb memories, such as the memory of where you 
were when President Kennedy was assassinated, pre- 
serve knowledge of an event in an almost indiscriminate 
way, much as a photograph preserves all the details of 
the scene. Initial studies on flashbulb memories focused 
on important historical events. But there is now good evi- 
dence that autobiographical details of surprising and im- 
portant defining personal events are retained with the 
same vivid clarity for details (Conway, 1995). 
How are the details of these dramatically personal and 
historical events stored? These surprising and emotionally 
charged events are thought to recruit the amygdala and 
the major arousal systems of the brain: the serotonergic, 
noradrenergic, dopaminergic, and cholinergic modulatory 
systems (McGaugh et al., 1993). One potential conse- 
quence of the action of these modulatory systems might 
be to relieve repression and thereby prime the memory 
system. It is therefore of particular interest that these mod- 
ulatory systems can play a significant role in the CREB- 
related learning in Aplysia, Drosophila, and mice. 
Experimental Procedures 
General Methods 
Standard manipulations of Escherichia coli, Saccharomyces cerevis- 
iae, proteins, and nucleic acids were performed essentially as de- 
scribed by Sambrook et al. (1989). Ausubel et al. (1994), and Harlow 
and Lane (1988). 
Plasmids and Cloning 
Cloning was generally done by PCR using Ultima DNA polymerase 
(Perkin Elmer). The Aplysia CNS-specific cDNA library was con- 
structed in pGADl0, and theApC/EBP bZlPdomain (amino acids 151- 
288) was cloned in pMA424 (Ma and Ptashne, 1987) (both provided 
by P. Bartels). Subsequent subcloning was carried out in pASl and 
pACT2 plasmids (Durfee et al., 1993) (both provided by S. Elledge). 
The initiation codons of ApCREB2, ApCIEBP, and ApCREBl were 
replaced by an Ncol restriction site by PCR and cloned in the Ncol- 
Sacl site of pGEX-KG (Guan and Dixon, 1991) or PET-30 (Novagen, 
modified by replacing the Ndel-Ncol fragment by a synthetic oligonu- 
cleotide encoding the initiating methionine followed by six histidines). 
The mammalian expression constructs pRcRSVApCREB2 and 
pRcRSV-ApCREBl were made by subcloning the corresponding 
cDNAs in pRcRSV (Invitrogen). The reporter pGL3-CRE was made 
by cloning a single CRE palindrome into a pGL3 promoter luciferase 
reporter plasmid (Promega). The plasmids pRcRSV-PKA C-al ex- 
pressing the PKA catalyticsubunit and pRcRSV-CREB341 expressing 
the wild-type rat CREB were provided by R. Goodman. 
Aplysia CNS cDNA Library Construction, Two-Hybrid Screening 
in Yeast, and GAL4 DNA-Binding Domain Activation Assay 
The Aplysia CNS cDNA library was synthesized in pGADl0 by use of 
random hexamers and the Bethesda Research Laboratories cDNA 
synthesis kit. Two libraries constructed from size-fractionated cDNAs 
with average inserts of >2 kb (5 x 1 O6 independent clones each) were 
used in the two-hybrid screening as described previously (Fields and 
Song, 1989; Durfee et al., 1993; Ausubel et al., 1994). The transcrip- 
tional activation properties of ApCREB2 and its interaction with other 
proteins in the two-hybrid system were analyzed by using the full-length 
ApCREB2 and its deletion mutants subcloned in pAS1 and pACT2 
vectors. The transcriptional activity of ApCREB2/GAL4 DNA-binding 
domain fusions was determined as described (Ma and Ptashne, 1987; 
Durfee et al., 1993). To analyze the protein interactions, ApCREB2, 
ApCIEBP, rat CREB, c-Fos, and deletion mutants of these proteins 
in pAS1 and pACT2 were cotransformed into S. cerevisiae Y190, and 
the expressed 8-galactosidase was quantified as above. 
Purification of Recombinant Proteins 
The induction and purification of GST fusion proteins were done as 
described (Frangioni and Neel, 1993). The Hiss-ApCREBP fusion pro- 
tein was expressed and purified with the QlAexpress system (Qiagen, 
denaturing protocol). The bound His,ApCREB2 protein was renatured 
on the nickel-nitrilotriacetic acid resin and eluted with 250 mM imid- 
azole. 
Antisera Production, Depletion, and Affinity Purification 
Two rabbit antisera were raised (BAbCO) against the GST-ApCREBP 
fusion protein and one against GST-ApCIEBP. The anti-ApCREB2 an- 
tisera were depleted of ApCREB2-specific antibodies by incubation 
with an equal volume of glutathione-agarose saturated (3 uglpl) with 
GST-ApCREB2 fusion protein. The matching controls for Western 
blots and electrophysiological experiments were prepared by parallel 
incubation of the immune antisera with glutathione-agarose saturated 
with GST. The antibodies were affinity-purified on the GST-ApCREB2 
andGST-ApCIEBP proteinscoupled toAffiGel(Bio-Rad). Priortopurifi- 
cation, the antisera were preadsorbed on the GST-AffiGel. 
Western Blotting 
Aplysia CNS extract (20 ng) was separated on 10% SDS-polyacryl- 
amide gels and electroblotted to polyvinylidene difluoride membranes 
(Immobilon P, Millipore). The membranes were probed with affinity- 
purified anti-ApCREBP, anti-ApCIEBP antibodies or anti-rat CREB an- 
tiserum (Upstate Biotechnology, Incorporated) followed by anti-rabbit- 
HRP and visualized by chemiluminescence (ECL, Amersham). 
lmmunoprecipitation 
The CNS ganglia removed from anesthetized Aplysia were labeled 
with [“Slmethionine overnight at 18% and homogenized in 10 mM 
Tris (pH 7.2), 350 mM NaCI, 0.5% Triton X-100, 50 mM f3-glycero- 
Cdl 
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phosphate, 25 mM NaF, 1 mM NaVO+ 2 mM DTT, 1 mM PMSF, 5 mM 
benzamidine, and 10 Kg/ml each of chymostatin, leupeptin, antipain, 
and pepstatin A. After dilution 1:l with 2x RIPA, the extract was pre- 
cleared with protein A-Sepharose for 1 hr at 4°C and incubated with 
affinity-purified anti-ApCREB2 antibody for 1 hr at 4OC followed by 
protein A-Sepharose (Pharmacia). The immunoprecipitated proteins 
were resolved by 10% SDS-polyacrylamide gel electrophoresis 
(PAGE) and visualized by fluorography (Amplify, Amersham). 
Phosphatase Treatment of Aplysia CNS Extracts 
Both phosphatase and mock buffer cocktails contained 20 mM MgClz, 
0.5 mM EGTA, 1 mM PMSF, 5 mM benzamidine, and 10 pglml each 
of chymostatin, leupeptin, antipain, and pepstatin A. The phosphatase 
mix contained 2 U of calf intestinal phosphatase, the mock mix 20 
mM NaF and 20 mM 6-glycerophosphate. These cocktails were added 
to 40 pg of the CNS extracts and incubated at 37OC for 30 min. The 
reactions were stopped by the addition of SDS sample buffer, and 
the proteins were visualized by Western blotting with affinity-purified 
anti-ApCREBP antibodies. 
RNA Extraction from Sensory Neuron Cultures and RT-PCR 
Cultures of approximately 200 Aplysia sensory neurons, established 
by the dissociation of the pleural sensory cluster in a single dish, were 
exposed to 10 uM 5-HT for 5 min either once or five times separated 
by 20 min. After washing with artificial sea water, cells were lysed by 
100 ~1 of the guanidium thiocyanate solution, and the RNA was iso- 
lated. For RT-PCR, the isolated RNA was treated with RNase-free 
DNase (Boehringer), reextracted as above, and processed with an 
RT-PCR kit (Boehringer). The sequences of the primers used were 
TTCCGCTTTCCATAAGTCGA and ACCTGAAAATGATATTGTAC. 
DNA-Binding Site Selection 
Optimal recognitionsequencesfor DNAbindingofApCREB2andApCl 
EBP were determined by a PCR-assisted binding site selection method 
(Norby et al., 1992). The oligonucleotides that bound in 150 mM KCI 
(standard isotonic condition) or 400 mM KCI (resembling Aplysia cell 
osmolarity) were eluted by 1 M KCI, diluted, and PCR amplified. After 
13 cycles of binding and PCR amplification, the amplified products 
were cloned in Bluescript (Stratagene) and sequenced. In each of the 
48 independent clones from both the low and the high salt conditions, 
the BSI binding sequence (for ApCREBP) or BS2 (for ApCIEBP) was 
present. 
In Vitro Protein Binding Assay 
[35S]methionine-labeled ApCREB2 and ApClEBP were translated in 
the TNT rabbit reticulocyte lysate (Promega). The lysates (IO ul) con- 
taining the in vitro translated proteins were mixed with 25 VI of glutathi- 
one-Sepharose beads saturated with glutathione S-transferase (GST) 
or GST fusion proteins in 400 frl of PBS and mixed for 1 hr at room 
temperature. The bound complexes were washed with 20 ml of 0.1% 
Triton X-100 in PBS on a minicolumn (Wizard, Promega), eluted in 
SDS sample buffer, and resolved by 10% SDS-PAGE. 
EMSA 
The sequences listed show one strand of the double-stranded oligonu- 
cleotides used in the EMSAs. The sequences in capital letters corre- 
spond to the particular elements listed: the somatostatin gene CRE 
(SOM CRE), gatccggcGCCTCCTTGGCTGACGTCAGAGAGAGAGA; 
the palindromic core CRE (CRE), gatccggcTGACGTCAtcaagcta; the 
phosphoenolpyruvate carboxykinase gene WE-1 (PEPCK CRE), 
gatccCCTTACGTCAGAGGCGA; the enkephalin gene CRE (ENK 
CRE), gatccggcGCGGGGCTGGCGTAGGGCCTGCGTCAGCTGCA); 
the ApC/EBP gene putative CRE (Ap CRE), GAGTGGCATCTACGT- 
CAAGGCTTC; the ApCRE62 DNA-binding sequence (BSI CRE), gatc- 
CggcAGTATTGCGTCATCtcaagcta; the composite CRE-CAAT site 
(CRE-CIEBP), gatccggcTGACGCAATtcaagcta; the angiotensin gene 
acute phase response element (ANG-APRE), gatccACAGTTGTGATT- 
TCACAACCTGACCAGA; the ApC/EBP DNA-binding sequence (BS2 
CIEBP), gatccggcACTATTGCGCAATCtcaagcta; and the CIEBPP- 
binding sequence of the c-fos promoter (ERE), gatcCATAlTAAGGA- 
CATGCCG. 
The EMSAs were performed as described by Ausubel et al. (1994), 
with the high ionic strength TGE buffer, 200 ng of recombinant Hiss- 
ApCREBP, 200 ng of poly(dl-dC) (Pharmacia), and 25 fmol of “P end- 
labeled double-stranded oligonucleotide probes. 
F9 Cell Culture, Transfections, and Reporter Gene Assays 
Undifferentiated mouse F9 cells were transfected with Lipofectamine 
(Bethesda Research Laboratories). The 6-galactosidase and lucifer- 
ase activities were quantitated by chemiluminescence (Galacton Plus, 
Tropix, and a Luciferase assay kit, Promega) in a Turner 20e lumino- 
meter. 
Aplysia Cell Culture and Electrophysiology 
Aplysia sensory neurons from the pleural ganglia of adult animals (80- 
100 g) were cocultured with the motor neuron L7 from juvenile animals 
(0.5-4.0 g). After 4-5 days in culture, the strength of the synaptic 
connections between the sensory and motor cell was measured elec- 
trophysiologically, as previously described (Montarolo et al., 1986; Al- 
berini et al., 1994). The motor neuron was impaled with a glass micro- 
electrode filled with 2.5 M KCI (10 MD resistance), and its membrane 
potential was held at 30 mV below its resting value. The EPSP was 
evoked by extracellular stimulation of the sensory neuron, and the 
data were stored on a four-channel tape recorder. 
Induction of Facilitation and Antisera Injection 
Two protocols were used to induce synaptic facilitation in Aplysia co- 
cultures. In the first, after testing the initial EPSP amplitude, 10 aM 
5-HT was applied for 5 min (single pulse). The EPSP was retested 
1 min (short-term facilitation), 2 or 24 hr (long-term facilitation) after 
the washout of the 5-HT. The amount of facilitation was calculated as 
the percentage change in EPSP amplitude recorded before and at the 
differenttimepointsafterthesingle5-HTapplication. In theothergroup 
of experiments, long-term facilitation was evoked by five exposures to 
10 PM 5-HT for 5 min each, at 20 min intervals (five pulses). The 
facilitation was calculated as the percentage change in EPSP ampli- 
tude 24 hr after the five pulses of 5-HT. The antisera, adjusted to the 
osmolarity of Aplysia neurons (Alberini et al., 1994), were pressure- 
injected into the sensory neurons 1 hr before 5-HT treatment. Where 
indicated, anisomycin (10 PM) or actinomycin D (50 pg/ml) was added 
to the cocultures 1 hr before the 5-HT pulse and was present continu- 
ously during the 5-HT treatment. All data are presented as mean per- 
centage change f SEM in the EPSP amplitude measured after treat- 
ment, as compared with its initial pretreatment amplitude. A one-way 
analysis of variance and Newman-Keuls multiple range test were used 
to determine the significance of the EPSP changes. 
Dye Injection, Cell Imaging, and Quantification 
of Structural Changes 
Individual sensory neurons were cocultured with a single motor cell. 
Glass micropipettes were filled with a 6% sterile-filtered solution of 
the fluorescent dye 5(6)-carboxyfluorescein (chromatographicallypuri- 
fied; Molecular Probes) in 0.44 M KOH (pH 7.0, resistance 50-90 MD). 
The dye was injected into the sensory neurons immediately after mea- 
surement of the initial EPSP amplitude by 0.4-0.6 nA hyperpolarizing 
current pulses (500 ms duration at 1 Hz) for 4-6 min; phase-contrast 
and fluorescence images of the same view areas were taken both 
before and 24 hr afler treatment as previously described (Glanzman 
et al., 1990; Bailey et al., 1992). 
Varicosities were identified according to criteria previously estab- 
lished for sensory neurons in viva (Baileyet al., 1979; Bailey and Chen, 
1983, 1988) and in vitro (Glanzman et al., 1990; Bailey et al., 1992) 
and included all slightly elongated spheres of approximately 2-3 urn 
or more in diameter. 
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